Repligen Corp (RGEN) Tops Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $167.60 -1.19%
Revenue Growth %: +9.4%
Financial Fact:
Research and development: 1.89M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +9.4%
Financial Fact:
Research and development: 1.89M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Repligen Corp (NASDAQ: RGEN) reported Q1 EPS of $0.00, $0.01 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $7.65 million versus the consensus estimate of $7.5 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Repligen (RGEN) PT Raised to $210 at HSBC
- Toro Company (TTC) Tops Q3 EPS by 3c; offers guidance
- Asana, Inc. (ASAN) Tops Q2 EPS by 1c; offers guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
